Pharmacist prescriber Penny Clark reviews the evidence for the benefit of empagliflozin in patients with heart failure, and highlights some factors to consider when implementing it alongside other cardiovascular and diabetes drugs
Pharmac has confirmed today they are funding a bundle deal which will give New Zealanders more effective treatment options for lung cancer and ovarian cancer
PEARLS #694: How do calcium channel blockers compare with other classes of antihypertensive drugs in reducing the incidence of major adverse cardiovascular events?
In a new report released today, the Prime Minister’s Chief Science Advisor is calling for action to combat infectious disease and antimicrobial resistance in Aotearoa New Zealand
Consultant cardiologist Chris Ellis discusses the recent funding of rosuvastatin, focusing on its use for secondary prevention of cardiovascular disease
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management